Compare Mesoblast Limited (MESO) vs Oklo Inc (OKLO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mesoblast Limited vs Oklo Inc — how do they compare? Mesoblast Limited trades at $16.38 (market cap $2.17B), while Oklo Inc trades at $46.8 (market cap $7.22B). The key difference: Oklo Inc is far larger — about 3.3× Mesoblast Limited's market cap, and Mesoblast Limited is trading nearer its 52-week high, Oklo Inc nearer its low. Which is the better fit depends on your goals.
| MESO | OKLO | |
|---|---|---|
Market Cap | $2.17B | $7.22B |
Sector | Technology | Technology |
52-Week High | $20.96 | $174.14 |
52-Week Low | $12.88 | $41.11 |
Enterprise Value | $2.17B | $5.02B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Mesoblast Limited
Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.
Read more on MESO →About Oklo Inc
Oklo Inc. is a company focused on developing and commercializing advanced fission power plants. The company specializes in micro-reactor technology, specifically the Aurora design, which uses advanced fuel to produce reliable, clean, and cost-competitive power. Oklo aims to provide scalable, on-site power solutions to various customers, including remote communities, industrial facilities, and government entities, positioning itself as an innovator in the next generation of nuclear energy.
Read more on OKLO →
